GlassScriptPhysician profile
Matthew Keith Hamilton
NPI 1649597089
$8,102.71
in general payments reported to CMS, 2019-2025
18 companies · $3,482 in 2025
The $3,482 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $599 · 2021: $745 · 2022: $576 · 2023: $1,416 · 2024: $1,123 · 2025: $3,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,766 · Travel and Lodging: $2,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,765.61 |
| Travel and Lodging | $2,255.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,413.58 | 2022-2025 | Octrode, Eterna, Penta |
| Stryker Corporation | $1,725.10 | 2025 | Mild Device Kit |
| Medtronic, INC. | $1,401.72 | 2021-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Forte Bio-Pharma LLC | $781.28 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $544.03 | 2020-2023 | |
| Medtronic USA, INC. | $419.59 | 2019-2020 | |
| Spinal Simplicity, LLC | $279.84 | 2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.39 | 2023-2025 | Relistor |
| Horizon Therapeutics Plc | $80.74 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $68.59 | 2022-2023 | Belbuca |
| Nevro Corp. | $68.52 | 2021-2023 | Senza |
| Curonix LLC | $46.62 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Hikma Pharmaceuticals USA | $38.86 | 2022 | |
| Arbor Pharmaceuticals, INC. | $29.85 | 2020-2021 | |
| Uswm, LLC | $28.64 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $22.76 | 2023 | Ztlido |
| Virtus Pharmaceuticals LLC | $22.47 | 2020 | |
| Saluda Medical Americas, INC. | $16.13 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.